1. Home
  2. APPF vs CYTK Comparison

APPF vs CYTK Comparison

Compare APPF & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AppFolio Inc.

APPF

AppFolio Inc.

HOLD

Current Price

$219.53

Market Cap

8.1B

Sector

Technology

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$63.78

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APPF
CYTK
Founded
2006
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
8.0B
IPO Year
2015
2004

Fundamental Metrics

Financial Performance
Metric
APPF
CYTK
Price
$219.53
$63.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
16
Target Price
$310.75
$84.81
AVG Volume (30 Days)
254.4K
1.8M
Earning Date
01-29-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
58.16
N/A
EPS
5.58
N/A
Revenue
$906,294,000.00
$87,211,000.00
Revenue This Year
$21.89
$339.72
Revenue Next Year
$18.58
$79.08
P/E Ratio
$39.29
N/A
Revenue Growth
18.88
2609.26
52 Week Low
$190.24
$29.31
52 Week High
$326.04
$70.98

Technical Indicators

Market Signals
Indicator
APPF
CYTK
Relative Strength Index (RSI) 43.32 51.02
Support Level $209.22 $62.25
Resistance Level $226.03 $65.38
Average True Range (ATR) 8.04 2.93
MACD -0.43 0.06
Stochastic Oscillator 33.99 64.02

Price Performance

Historical Comparison
APPF
CYTK

About APPF AppFolio Inc.

AppFolio Inc provides cloud-based software solutions for the real estate industry. Its property management software offers property managers an end-to-end solution to their business needs. The group's products include cloud-based property management software (Appfolio Property Manager). Its solutions are AppFolio Property Manager Core, AppFolio Property Manager Plus, and AppFolio Property Manager Max. It also offers value-added services, such as screening, risk mitigation, and electronic payment services. Its markets are Single-Family, Multifamily, Student Housing, Affordable Housing, Community Associations, Commercial, and Investment Management. The business activity of the firm predominantly functions in the United States and it generates revenue in the form of subscription fees.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: